1,3-Benzodioxolyl-N-ethylpentanamine
| Clinical data | |
|---|---|
| Other names | N-Ethyl-1,3-benzodioxolylpentanamine; 1,3-Benzodioxolyl-N-ethylpentanamine; EBDP; 3,4-Methylenedioxy-α-propyl-N-ethylphenethylamine |
| Routes of administration | Oral |
| ATC code |
|
| Pharmacokinetic data | |
| Duration of action | Unknown |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C14H21NO2 |
| Molar mass | 235.327 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
EBDP, also known as N-ethyl-1,3-benzodioxolylpentanamine, 3,4-methylenedioxy-N-ethyl-α-propylphenethylamine, or ethyl-K, is a psychoactive drug of the phenethylamine, amphetamine, and MDxx families. It is the N-ethyl analogue of BDP (K).